Browse Title Index
Issue | Title | |
Vol 57, No 6 (2023) | Reperfusion therapy of ischaemic strokes in oral anticoagulated patients: an expanding field in clinical practice | Details |
Bartosz Karaszewski | ||
Vol 54, No 4 (2020) | Reply to the Letter to the Editors: DBS patient with diagnosed Non-Hodgkin’s lymphoma: is radiation therapy safe? | Details PDF |
Michał J. Schinwelski, Jarosław Dulski, Wojciech Łuczak, Witold Libionka, Tomasz Mandat, Jarosław Sławek | ||
Vol 56, No 3 (2022) | Response relating to the article 'Primary progressive multiple sclerosis overlapping with anti-GAD and anti-Hu antibodies positive neurological syndromes' | Details |
Pavel Štourač, Jana Bednářová, Zbyšek Pavelek, Martin Vališ | ||
Vol 57, No 3 (2023) | Response to Letter to the Editors regarding article entitled ‘Left ventricular non-compaction cardiomyopathy and ischaemic stroke’ | Details |
Cătălina Elena Bistriceanu, Florentina Anca Danciu, Dan Iulian Cuciureanu | ||
Vol 57, No 3 (2023) | Response to Letter to the Editors regarding article entitled ‘Sex-related patient-reported brain fog symptoms in nonhospitalised COVID-19 patients’ | Details |
Żaneta Chatys-Bogacka, Iwona Mazurkiewicz, Joanna Słowik, Klaudia Nowak, Wojciech Sydor, Barbara Wizner, Agnieszka Słowik, Marcin Wnuk, Leszek Drabik | ||
Vol 57, No 2 (2023) | Response to the Letter to the Editors on the article reviewing the complex subject of ‘Impact of SARS-CoV-2 on the nervous system’ | Details PDF HTML |
Agata Czarnowska, Joanna Zajkowska, Alina Kułakowska | ||
Vol 57, No 4 (2023) | Response to ‘Before blaming levodopa/carbidopa intestinal gel for demyelinating polyneuropathy, all differential aetiologies must be ruled out’ | Details |
Radosław Piekarski, Anna Roszmann, Jarosław Dulski, Jarosław Sławek | ||
Vol 56, No 1 (2022) | Response to ‘Neuro-COVID due to the response against the virus’ Letter | Details |
Jolanta Bratosiewicz-Wąsik | ||
Vol 57, No 5 (2023) | Response to ‘Neurologists should retain diagnostic and therapeutic management of migraines’ | Details |
Magdalena Boczarska-Jedynak | ||
Vol 54, No 3 (2020) | Response to “Does amantadine have a protective effect against COVID-19?” | Details PDF |
Philip W. Tipton, Zbigniew K. Wszolek | ||
Vol 57, No 6 (2023) | Reversing dabigatran effect with idarucizumab to enable intravenous thrombolysis in patients with acute ischaemic stroke — a single centre experience | Abstract |
Ewa Włodarczyk, Katarzyna Sawczyńska, Paweł Wrona, Agnieszka Słowik | ||
Vol 54, No 2 (2020) | Risk factors for death by acute ischaemic stroke in patients from West-Pomerania, Poland | Abstract PDF |
Paweł Wańkowicz, Monika Gołąb-Janowska, Przemysław Nowacki | ||
Vol 57, No 5 (2023) | Risk factors for dementia in Parkinson’s Disease — the overuse of anticholinergic drugs | Abstract |
Jakub J. Malkiewicz, Amadeusz G. Kasprzyk, Damian Waksmundzki, Julia Węgrzynek, Tomasz Chmiela, Joanna Siuda | ||
Vol 56, No 5 (2022) | Risk factors for infarct growth and haemorrhagic or oedematous complications after endovascular treatment — a literature review | Abstract |
Izabella Tomaszewska-Lampart, Marcin Wiącek, Halina Bartosik-Psujek | ||
Vol 48, No 5 (2014) | Risk factors for re-bleeding of aneurysmal subarachnoid hemorrhage: Meta-analysis of observational studies | Abstract PDF |
Gobran Taha Ahmed Alfotih, FangCheng Li, XinKe Xu, ShangYi Zhang | ||
391 - 405 of 540 Items | << < 22 23 24 25 26 27 28 29 30 31 > >> |